Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cariogenic bacterial enolase is a highly conserved metalloenzyme (EC 4.2.1.11) found in caries-forming bacteria such as Streptococcus mutans. It catalyzes a critical step in glycolysis—the conversion of 2-phosphoglycerate to phosphoenolpyruvate—supporting bacterial metabolism under anaerobic, acidic conditions typical of dental biofilms. Enolase also exhibits 'moonlighting' functions, including involvement in RNA degradation complexes and serving as a plasminogen receptor on the bacterial surface, facilitating host interaction and colonization. Its essential role in bacterial survival, virulence, acid tolerance, and biofilm formation makes it a promising and validated target for the development of novel antimicrobial and anti-caries therapies. Potent small-molecule inhibitors, such as natural and synthetic tropolones, have demonstrated enolase inhibitory activity and bactericidal effects against cariogenic pathogens.
Inhibition of enolase activity blocks glycolysis, compromising bacterial energy metabolism, especially under acidic, biofilm-forming conditions. Inhibitors may chelate the catalytic Mg²⁺ cofactors or bind to active site residues, preventing substrate (2-phosphoglycerate) conversion to product (phosphoenolpyruvate). For some agents (e.g., tropolones), interaction with the metalloenzyme active site inhibits catalytic function and thus impairs bacterial growth and survival.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enolase from cariogenic bacteria (Eno).